In a time of uncertainty and financial pressure, this issue of Primary Care Respiratory Update (PCRU) is a vital resource for anyone working in respiratory care. As Integrated Care Boards across England face significant budget cuts, programmes that have taken years to build are now under threat.
Taxonomy: Allergy, Asthma, Current, Greener Healthcare, Inhaler devices, PCRU, 1 hour
Taxonomy: Asthma, Behaviour change, COPD, Current, Inhaler devices, Respiratory tests and investigations, Videos / Webinars, 30 minutes, PCRS Produced / Collaboration
For our next In Conversation Katherine was joined by Dr Richard Russell, a man of many respiratory interested hats!
Taxonomy: Asthma, Behaviour change, Inhaler devices, Videos / Webinars, PCRS Produced / Collaboration
Joining us on Wednesday 21st May, 19:30-20:00, for our next In Conversation is Dr Richard Russell, a man of many respiratory interested hats!
Taxonomy: Asthma, Current, Inhaler devices, Press Release, PCRS Produced / Collaboration
The Primary Care Respiratory Society (PCRS) and Asthma + Lung UK call for urgent action to address the growing number of online pharmacies selling salbutamol inhalers without appropriate medical oversight.
The webinar will be held on Friday 9 May 2025 at 19:00 for 45 minutes. Chaired by Katherine Hickman (our PCRS Executive Chair), she and guest speakers, Deborah Leese and Marieke Strange, will focus on:
Taxonomy: 15 minutes, Asthma, Current, Inhaler devices, PCRS Position Statement, PCRS Produced / Collaboration
2024 marked a pivotal change in the management of asthma in the UK with the publication of a joint British Thoracic Society (BTS), National Institute for Health and Care Excellence (NICE) and Scottish Intercollegiate Guidelines Network (SIGN) guideline.
Taxonomy: 15 minutes, Clinical resource or information, Current, Greener Healthcare, Inhaler devices, PCRS Produced / Collaboration
The NHS is under increased financial and environmental pressures. Blanket switching of medications (changing medication from one to another without patient consultation) to more cost-effective and environmentally friendly options is therefore becoming more common.
Taxonomy: Asthma, Current, Inhaler devices, PCRU, 30 minutes, PCRS Produced / Collaboration
The National Review of Asthma Deaths (NRAD) came out a decade ago, yet as a nation, we still have the highest asthma death rate in Europe - four times that of Italy or the Netherlands. This is unsurprising, considering many patients still rely on their blue inhalers alone.
Taxonomy: Allergy, COPD, Current, Health inequalities, Inhaler devices, PCRU, 1 hour
Taxonomy: Asthma, Current, Inhaler devices, Videos / Webinars, PCRS Produced / Collaboration, 1 hour
Let's be MART for asthma.
Taxonomy: Asthma, Current, Inhaler devices, Videos / Webinars, PCRS Produced / Collaboration, 1 hour
Be proactive, not reactive.
The webinar will be held on Wednesday 9th October 2024 at 19:00 for 45 minutes. Chaired by Katherine Hickman (our PCRS Executive Chair), she and guest speaker, Noreen Grant (GP), will focus on:
Taxonomy: Current, Greener Healthcare, Inhaler devices, PCRS Position Statement, PCRS Produced / Collaboration
Concerns about the environmental impact of the propellant gases used in pressurised metered dose inhalers (pMDIs) and the plastics used in all single-use inhaler devices have made them an important focus for efforts to reduce the environmental impact of the NHS.
Taxonomy: 15 minutes, COPD, Current, Inhaler devices, PCRS Position Statement, PCRS Produced / Collaboration
The Primary Care Respiratory Society (PCRS) advocates a pragmatic approach to the pharmacological management of patients with chronic obstructive pulmonary disease (COPD) guided by the predominance of breathlessness and/or exacerbations and the presence or absence of comorbid asthma.
Taxonomy: 15 minutes, Asthma, Current, Inhaler devices, PCRU, PCRS Produced / Collaboration
The Medicines and Healthcare Products Regulatory Agency (MHRA) has for the first time approved the use of a dual (ICS/beta-agonist) combination treatment to be prescribed as a reliever therapy for people aged 12 and over with the therapy choice situated early in the asthma treatment pathway as an